Medios AG (LON:0QB4)

Market Cap	268.70M
Revenue (ttm)	1.53B
Net Income (ttm)	10.71M
Shares Out	n/a
EPS (ttm)	0.44
PE Ratio	25.08
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,452
Average Volume	5,095
Open	13.00
Previous Close	13.00
Day's Range	12.62 - 13.01
52-Week Range	13.30 - 20.60
Beta	1.05
RSI	55.24
Earnings Date	Mar 28, 2025

About Medios AG

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, p...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 2016
• Employees: 515
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QB4

Financial Performance

In 2023, Medios AG's revenue was 1.78 billion, an increase of 10.71% compared to the previous year's 1.61 billion. Earnings were 18.81 million, an increase of 2.62%.

Financial numbers in EUR